insights_auto
EVGN の下落理由: 9.41%?
さらに詳しくchevron_right
EVGN:NASDAQ
エボジェン
$0.38
arrow_downward
-9.41%(-0.040) 1 日
10月5日, 14:34:46 GMT-4 · USD
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoEVGN の上位の分析情報を生成しています...
始値
$0.41
高値
$0.41
安値
$0.37
時価総額
601.28万
平均出来高
256.60万
取引量
47.77万
52 週高値
$1.50
52 週安値
$0.35
EPS
-$0.91
ベータ版
1.44
発行済株式数
1580.10万
従業員数
52
始値
$0.41
高値
$0.41
安値
$0.37
時価総額
601.28万
平均出来高
256.60万
取引量
47.77万
52 週高値
$1.50
52 週安値
$0.35
EPS
-$0.91
ベータ版
1.44
発行済株式数
1580.10万
従業員数
52
ニュース記事
情報源: ウェブソース、ニュース パートナー
AD HOC NEWS
·
8 時間前
Evogene stock fell 2.43 percent as Nasdaq deadline moved
プロフィール
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
エボジェン について